Yu Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yu Fan has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Yong Hu
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai, China
7 shared publications - Jianzhong Du
East China University of Science and Technology
5 shared publications - Beibei Zhang
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
4 shared publications - Yuyan Qian
Department of Polymeric Materials, School of Materials Science and Engineering
3 shared publications - Chang Li
Department of Spine Surgery Shanghai East Hospital School of Medicine Tongji University Shanghai 200120 China
2 shared publications - Danqing Liu
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
2 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (8) , 1105
Design of Spherical Nucleic Acids: From Fast Synthesis to Structural Engineering
Since the introduction of the spherical nucleic acid (SNA) paradigm in 1996, extensive research has been dedicated to this burgeoning field, yielding groundbreaking advances in biomedicine. Featuring a unique three-dimensional spherical nanoarchitecture composed of highly oriented, densely packed oligonucleotide layers conjugated to a solid or hollow core, SNAs possess extraordinary biological properties, including transfection-reagent-independent cellular internalization and enhanced resistance to nuclease degradation. These synthetic and foundational evolutionary milestones offer profound advantages for the rational design of targeted biomedical therapeutics. In this comprehensive review, recent breakthroughs in the synthetic methodologies and structural designs of SNAs, with a particular emphasis on gold-based templates, are systematically summarized and discussed. Furthermore, the core bottlenecks and future perspectives emerging at the intersection of artificial intelligence and high-throughput screening are highlighted to guide next-generation intelligent nanomedicine development.
- 29 July 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (8) , 1105
Open AccessDesign of Spherical Nucleic Acids: From Fast Synthesis to Structural Engineering
Since the introduction of the spherical nucleic acid (SNA) paradigm in 1996, extensive research has been dedicated to this burgeoning field, yielding groundbreaking advances in biomedicine. Featuring a unique three-dimensional spherical nanoarchitecture composed of highly oriented, densely packed oligonucleotide layers conjugated to a solid or hollow core, SNAs possess extraordinary biological properties, including transfection-reagent-independent cellular internalization and enhanced resistance to nuclease degradation. These synthetic and foundational evolutionary milestones offer profound advantages for the rational design of targeted biomedical therapeutics. In this comprehensive review, recent breakthroughs in the synthetic methodologies and structural designs of SNAs, with a particular emphasis on gold-based templates, are systematically summarized and discussed. Furthermore, the core bottlenecks and future perspectives emerging at the intersection of artificial intelligence and high-throughput screening are highlighted to guide next-generation intelligent nanomedicine development.
- 4 July 2026
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 38 (13) , 7041-7042
Correction to “Injectable DNA Hydrogels with Intrinsic Antioxidant and Anti-inflammatory Functions for Effectively Healing Bacteria-Infected Diabetic Wounds”
- 4 July 2026
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 38 (13) , 7041-7042
Correction to “Injectable DNA Hydrogels with Intrinsic Antioxidant and Anti-inflammatory Functions for Effectively Healing Bacteria-Infected Diabetic Wounds”
- 12 March 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (9) , 2384-2402
Copper sulfide nanoparticles coated with Fe-EGCG networks for targeted MR imaging and chemo/photothermal/chemodynamic synergetic therapy of tumors
Despite the extensive application of copper sulfide nanoparticles (CuS NPs) as photothermal therapeutic agents in biomedical fields, their efficient tumor theranostics via specific delivery and multimodal therapy remains a formidable challenge. In this study, functional CuS NPs coated with iron ( Fe)-(-)-epigallocatechin gallate (EGCG) metal polyphenolic networks (MPNs) were synthesized for targeted magnetic resonance (MR) imaging-directed chemo/photothermal/chemodynamic synergetic therapy of tumors. The nanocomposites were prepared using polyethylene glycol (PEG)-conjugated folic acid (FA) and fluorescein isothiocyanate (FI) pre-modified polyethylenimine (PEI.NH2) as a nanotemplate, followed by in situ formation of CuS NPs within its internal cavity, acetylation of surface amines, and Fe-EGCG MPNs coating. The resulting FA-CuS PENs@Fe-EGCG nanocomposites with an average diameter of 10.81 nm exhibit eminent photothermal conversion efficiency (51.1%), great colloidal and photothermal stability, favorable T1 relaxivity (r1 = 4.8005 mM -1 s -1 ), pH/near infrared (NIR) laser dual-responsive drug release characteristics, and enhanced Fenton reaction catalytic activity. The active targeting effect of FA enables the specific cellular uptake of FA-CuS PENs@Fe-EGCG nanocomposites by cancer cells overexpressing FA receptors, facilitating targeted tumor T1-weighted MR imaging in vitro and in vivo. Notably, EGCG and NIR laser irradiation could enhance Fe-mediated Fenton reaction efficiency, increasing hydroxyl radical (•OH) production and potentiating chemodynamic therapy efficacy. Through effectively generating reactive oxygen species (ROS), consuming glutathione (GSH), accumulating lipid peroxidation (LPO), and promoting cancer cell apoptosis under laser irradiation, the FA-CuS PENs@Fe-EGCG nanocomposites could exert superior tumor suppression efficacy in the 4T1 xenograft mice model by targeted chemo/photothermal/chemodynamic synergetic therapy. This work presents a succinct design of advanced nanocomposites incorporating CuS NPs and MPNs, offering a promising strategy for tumor theranostics.
- 12 March 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 14 (9) , 2384-2402
Copper sulfide nanoparticles coated with Fe-EGCG networks for targeted MR imaging and chemo/photothermal/chemodynamic synergetic therapy of tumors
Despite the extensive application of copper sulfide nanoparticles (CuS NPs) as photothermal therapeutic agents in biomedical fields, their efficient tumor theranostics via specific delivery and multimodal therapy remains a formidable challenge. In this study, functional CuS NPs coated with iron ( Fe)-(-)-epigallocatechin gallate (EGCG) metal polyphenolic networks (MPNs) were synthesized for targeted magnetic resonance (MR) imaging-directed chemo/photothermal/chemodynamic synergetic therapy of tumors. The nanocomposites were prepared using polyethylene glycol (PEG)-conjugated folic acid (FA) and fluorescein isothiocyanate (FI) pre-modified polyethylenimine (PEI.NH2) as a nanotemplate, followed by in situ formation of CuS NPs within its internal cavity, acetylation of surface amines, and Fe-EGCG MPNs coating. The resulting FA-CuS PENs@Fe-EGCG nanocomposites with an average diameter of 10.81 nm exhibit eminent photothermal conversion efficiency (51.1%), great colloidal and photothermal stability, favorable T1 relaxivity (r1 = 4.8005 mM -1 s -1 ), pH/near infrared (NIR) laser dual-responsive drug release characteristics, and enhanced Fenton reaction catalytic activity. The active targeting effect of FA enables the specific cellular uptake of FA-CuS PENs@Fe-EGCG nanocomposites by cancer cells overexpressing FA receptors, facilitating targeted tumor T1-weighted MR imaging in vitro and in vivo. Notably, EGCG and NIR laser irradiation could enhance Fe-mediated Fenton reaction efficiency, increasing hydroxyl radical (•OH) production and potentiating chemodynamic therapy efficacy. Through effectively generating reactive oxygen species (ROS), consuming glutathione (GSH), accumulating lipid peroxidation (LPO), and promoting cancer cell apoptosis under laser irradiation, the FA-CuS PENs@Fe-EGCG nanocomposites could exert superior tumor suppression efficacy in the 4T1 xenograft mice model by targeted chemo/photothermal/chemodynamic synergetic therapy. This work presents a succinct design of advanced nanocomposites incorporating CuS NPs and MPNs, offering a promising strategy for tumor theranostics.
- 3 July 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (27) , 25204-25227
Double-Layer Nucleoside-Microneedles Co-Delivering Dexamethasone Vesicles and Adenosine Overcome Pseudomembrane Barriers for the Treatment of Oral Ulcer
Oral ulcers are common, painful mucosal lesions that significantly impair patients' quality of life. The dynamic and moist oral environment, pseudomembrane formation, and limitations of corticosteroid therapies present ongoing clinical challenges. To address these important challenges, we developed double-layer microneedles integrating three functional components: a rapidly dissolving poly(vinyl alcohol) (PVA) substrate for immediate mucosal adhesion, nucleoside-based microneedles for pseudomembrane penetration and oxidative stress relief, and dexamethasone-loaded polymer vesicles (Dex-PVs). The vesicle improves the bioavailability of dexamethasone and enables a slow, sustained release, enhancing its therapeutic effects. Nucleoside microneedles, incorporating adenosine, synergistically enhance anti-inflammatory and analgesic effects by reducing the release of inflammatory cytokines and decreasing neuronal excitability and reverse the glucocorticoid-induced inhibition of cell migration by promoting CD31 and Ki67 expression. In vivo experiments confirmed that the microneedle reduced the ulcer area to 6.3% after 9 days of treatment (a 69.3% reduction compared to commercial formulations), with significant analgesic effects. This multiscale engineering approach addresses key challenges in oral drug retention, pseudomembrane penetration, and healing regulation, offering a paradigm for the treatment of mucosal diseases.
- 3 July 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (27) , 25204-25227
Double-Layer Nucleoside-Microneedles Co-Delivering Dexamethasone Vesicles and Adenosine Overcome Pseudomembrane Barriers for the Treatment of Oral Ulcer
Oral ulcers are common, painful mucosal lesions that significantly impair patients' quality of life. The dynamic and moist oral environment, pseudomembrane formation, and limitations of corticosteroid therapies present ongoing clinical challenges. To address these important challenges, we developed double-layer microneedles integrating three functional components: a rapidly dissolving poly(vinyl alcohol) (PVA) substrate for immediate mucosal adhesion, nucleoside-based microneedles for pseudomembrane penetration and oxidative stress relief, and dexamethasone-loaded polymer vesicles (Dex-PVs). The vesicle improves the bioavailability of dexamethasone and enables a slow, sustained release, enhancing its therapeutic effects. Nucleoside microneedles, incorporating adenosine, synergistically enhance anti-inflammatory and analgesic effects by reducing the release of inflammatory cytokines and decreasing neuronal excitability and reverse the glucocorticoid-induced inhibition of cell migration by promoting CD31 and Ki67 expression. In vivo experiments confirmed that the microneedle reduced the ulcer area to 6.3% after 9 days of treatment (a 69.3% reduction compared to commercial formulations), with significant analgesic effects. This multiscale engineering approach addresses key challenges in oral drug retention, pseudomembrane penetration, and healing regulation, offering a paradigm for the treatment of mucosal diseases.
- 26 May 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (22) , 9139-9148
Circularization of Aptamer Nanomedicine Improves Nuclease Resistance, Targeted Recognition, and Transdermal Effect for Topical Psoriasis Therapy
Inhibiting excessive hyperproliferation and inflammatory responses of keratinocytes are two primary tasks against psoriasis, which, however, have not been well integrated by the current available nanomedicines. Herein, we develop a nucleic acid nanomedicine through coassembly of circular aptamers and gold nanoclusters via electrostatic interactions for psoriasis therapy. After topical application, this nanomedicine bearing vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) aptamers crosses the stratum corneum and enters the deep layers of psoriatic site, from which it specifically inhibits VEGF-mediated keratinocyte proliferation and TNF-α-mediated inflammatory responses simultaneously. More importantly, the circular aptamers further promote the nuclease resistance, targeted recognition, and transdermal effect of the nanomedicine, as compared to their linear counterparts. These improved synergistic actions effectively prevent and cure psoriasis of mice induced by imiquimod. It is anticipated that this study provides a general strategy for targeted regulation of intricate pathological microenvironments beyond psoriasis.
- 26 May 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (22) , 9139-9148
Circularization of Aptamer Nanomedicine Improves Nuclease Resistance, Targeted Recognition, and Transdermal Effect for Topical Psoriasis Therapy
Inhibiting excessive hyperproliferation and inflammatory responses of keratinocytes are two primary tasks against psoriasis, which, however, have not been well integrated by the current available nanomedicines. Herein, we develop a nucleic acid nanomedicine through coassembly of circular aptamers and gold nanoclusters via electrostatic interactions for psoriasis therapy. After topical application, this nanomedicine bearing vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) aptamers crosses the stratum corneum and enters the deep layers of psoriatic site, from which it specifically inhibits VEGF-mediated keratinocyte proliferation and TNF-α-mediated inflammatory responses simultaneously. More importantly, the circular aptamers further promote the nuclease resistance, targeted recognition, and transdermal effect of the nanomedicine, as compared to their linear counterparts. These improved synergistic actions effectively prevent and cure psoriasis of mice induced by imiquimod. It is anticipated that this study provides a general strategy for targeted regulation of intricate pathological microenvironments beyond psoriasis.
- 14 April 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (16) , 15444-15456
Circularized Supramolecular Spherical Nucleic Acids Alleviates Liver Fibrosis through Blocking Upstream Activation and Reversing Activation State of Hepatic Stellate Cells
Inhibition of hepatic stellate cell (HSC) activation and reversal of its activation state represent two distinct yet complementary strategies in antifibrotic therapy. While synergy of those two strategies is anticipated to improve the therapeutic outcomes, synergism through nanomedicine remains elusive. Herein, we report a circular spherical nucleic acid (cSNA) with a supramolecular core comprising collagenase I and ML-290 and a surface attached with circular PDGF-BB aptamer instead of the stereotypical linear counterpart. Unlike conventional inert SNA, this cSNA core dissociates in response to elevated ROS levels in the fibrotic liver so that collagenase I is released to disrupt the collagen barrier to promote the penetration of ensuing nanoparticles. Of significant importance is that the PDGF-BB aptamer after circularization exhibits enhanced nuclease resistance and improved molecular recognition, thereby demonstrating superior capability in blocking HSC activation mediated by PDGF-BB/PDGFR-β signaling. Meanwhile, relaxin family peptide receptor 1 (RXFP1) agonist ML-290 initially transforms pro-fibrogenic macrophages into pro-resolution macrophages by activating RXFP1 signaling, facilitating the secretion of pro-resolution factors for the reversal of the activated state of HSCs. This work thus presents a proof-of-concept demonstration of a supramolecular SNA that undergoes structural and functional refinements, enabling concurrent upstream etiological blockade and downstream pathological restoration in liver fibrosis.
- 14 April 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (16) , 15444-15456
Circularized Supramolecular Spherical Nucleic Acids Alleviates Liver Fibrosis through Blocking Upstream Activation and Reversing Activation State of Hepatic Stellate Cells
Inhibition of hepatic stellate cell (HSC) activation and reversal of its activation state represent two distinct yet complementary strategies in antifibrotic therapy. While synergy of those two strategies is anticipated to improve the therapeutic outcomes, synergism through nanomedicine remains elusive. Herein, we report a circular spherical nucleic acid (cSNA) with a supramolecular core comprising collagenase I and ML-290 and a surface attached with circular PDGF-BB aptamer instead of the stereotypical linear counterpart. Unlike conventional inert SNA, this cSNA core dissociates in response to elevated ROS levels in the fibrotic liver so that collagenase I is released to disrupt the collagen barrier to promote the penetration of ensuing nanoparticles. Of significant importance is that the PDGF-BB aptamer after circularization exhibits enhanced nuclease resistance and improved molecular recognition, thereby demonstrating superior capability in blocking HSC activation mediated by PDGF-BB/PDGFR-β signaling. Meanwhile, relaxin family peptide receptor 1 (RXFP1) agonist ML-290 initially transforms pro-fibrogenic macrophages into pro-resolution macrophages by activating RXFP1 signaling, facilitating the secretion of pro-resolution factors for the reversal of the activated state of HSCs. This work thus presents a proof-of-concept demonstration of a supramolecular SNA that undergoes structural and functional refinements, enabling concurrent upstream etiological blockade and downstream pathological restoration in liver fibrosis.
- 5 August 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (33) , 22431-22443
Polyaptamer-Driven Crystallization of Alendronate for Synergistic Osteoporosis Treatment through Osteoclastic Inhibition and Osteogenic Promotion
Osteoclastic inhibition using antiresorptive bisphosphonates and osteogenic promotion using antisclerostin agents represent two distinct osteoporosis treatments in clinical practice, each individual treatment suffers from unsatisfactory therapeutic efficacy due to its indirect intervention in osteoclasis and promotion of osteogenesis simultaneously. Although this issue is anticipated to be resolved by drug synergism, a tempting carrier-free dual-medication nanoassembly remains elusive. Herein, we prepare such a nanoassembly made of antiresorptive alendronate (ALN) crystal and antisclerostin polyaptamer (Apt) via a nucleic acid-driven crystallization method. This nanoparticle can protect Apt from rapid nuclease degradation, avoid the high cytotoxicity of free ALN, and effectively concentrate in the cancellous bone by virtue of the bone-binding ability of DNA and ALN. More importantly, the acid microenvironment of cancellous bone triggers the disassociation of nanoparticles for sustained drug release, from which ALN inhibits the osteoclast-mediated bone resorption while Apt promotes osteogenic differentiation. Our work represents a pioneering demonstration of nucleic acid-driven crystallization of a bisphosphonate into a tempting carrier-free dual-medication nanoassembly. This inaugural advancement augments the antiosteoporosis efficacy through direct inhibition of osteoclasis and promotion of osteogenesis simultaneously and establishes a paradigm for profound understanding of the underlying synergistic antiosteoporosis mechanism of antiresorptive and antisclerostin components. It is envisioned that this study provides a highly generalizable strategy applicable to the tailoring of a diverse array of DNA-inorganic nanocomposites for targeted regulation of intricate pathological niches.
- 5 August 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (33) , 22431-22443
Polyaptamer-Driven Crystallization of Alendronate for Synergistic Osteoporosis Treatment through Osteoclastic Inhibition and Osteogenic Promotion
Osteoclastic inhibition using antiresorptive bisphosphonates and osteogenic promotion using antisclerostin agents represent two distinct osteoporosis treatments in clinical practice, each individual treatment suffers from unsatisfactory therapeutic efficacy due to its indirect intervention in osteoclasis and promotion of osteogenesis simultaneously. Although this issue is anticipated to be resolved by drug synergism, a tempting carrier-free dual-medication nanoassembly remains elusive. Herein, we prepare such a nanoassembly made of antiresorptive alendronate (ALN) crystal and antisclerostin polyaptamer (Apt) via a nucleic acid-driven crystallization method. This nanoparticle can protect Apt from rapid nuclease degradation, avoid the high cytotoxicity of free ALN, and effectively concentrate in the cancellous bone by virtue of the bone-binding ability of DNA and ALN. More importantly, the acid microenvironment of cancellous bone triggers the disassociation of nanoparticles for sustained drug release, from which ALN inhibits the osteoclast-mediated bone resorption while Apt promotes osteogenic differentiation. Our work represents a pioneering demonstration of nucleic acid-driven crystallization of a bisphosphonate into a tempting carrier-free dual-medication nanoassembly. This inaugural advancement augments the antiosteoporosis efficacy through direct inhibition of osteoclasis and promotion of osteogenesis simultaneously and establishes a paradigm for profound understanding of the underlying synergistic antiosteoporosis mechanism of antiresorptive and antisclerostin components. It is envisioned that this study provides a highly generalizable strategy applicable to the tailoring of a diverse array of DNA-inorganic nanocomposites for targeted regulation of intricate pathological niches.
- 29 November 2023
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 35 (23) , 9963-9977
Injectable DNA Hydrogels with Intrinsic Antioxidant and Anti-inflammatory Functions for Effectively Healing Bacteria-Infected Diabetic Wounds
- 29 November 2023
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 35 (23) , 9963-9977
Injectable DNA Hydrogels with Intrinsic Antioxidant and Anti-inflammatory Functions for Effectively Healing Bacteria-Infected Diabetic Wounds
- Open Access
- 4 August 2023
- Published by Wiley in Advanced Science
- Vol. 10 (29) , e2302119
Programming Injectable DNA Hydrogels Yields Tumor Microenvironment‐Activatable and Immune‐Instructive Depots for Augmented Chemo‐Immunotherapy
Injectable hydrogels have attracted increasing attention for promoting systemic antitumor immune response through the co‐delivery of chemotherapeutics and immunomodulators. However, the biosafety and bioactivity of conventional hydrogel depots are often impaired by insufficient possibilities for post‐gelling injection and means for biofunction integration. Here, an unprecedented injectable stimuli‐responsive immunomodulatory depot through programming a super‐soft DNA hydrogel adjuvant is reported. This hydrogel system encoded with adenosine triphosphate aptamers can be intratumorally injected in a gel formulation and then undergoes significant molecular conformation change to stimulate the distinct release kinetics of co‐encapsulated therapeutics. In this scenario, doxorubicin is first released to induce immunogenic cell death that intimately works together with the polymerized cytosine‐phosphate‐guanine oligodeoxynucleotide (CpG ODN) in gel scaffold for effectively recruiting and activating dendritic cells. The polymerized CpG ODN not only enhances tumor immunogenicity but minimizes free CpG‐induced splenomegaly. Furthermore, the subsequently released anti‐programmed cell death protein ligand 1 (aPDL1) blocks the corresponding immune inhibitory checkpoint molecule on tumor cells to sensitize antitumor T‐cell immunity. This work thus contributes to the first proof‐of‐concept demonstration of a programmable super‐soft DNA hydrogel system that perfectly matches the synergistic therapeutic modalities based on chemotherapeutic toxicity, in situ vaccination, and immune checkpoint blockade.
- 4 August 2023
- Published by Wiley in Advanced Science
- Vol. 10 (29) , e2302119
Open AccessProgramming Injectable DNA Hydrogels Yields Tumor Microenvironment‐Activatable and Immune‐Instructive Depots for Augmented Chemo‐Immunotherapy
Injectable hydrogels have attracted increasing attention for promoting systemic antitumor immune response through the co‐delivery of chemotherapeutics and immunomodulators. However, the biosafety and bioactivity of conventional hydrogel depots are often impaired by insufficient possibilities for post‐gelling injection and means for biofunction integration. Here, an unprecedented injectable stimuli‐responsive immunomodulatory depot through programming a super‐soft DNA hydrogel adjuvant is reported. This hydrogel system encoded with adenosine triphosphate aptamers can be intratumorally injected in a gel formulation and then undergoes significant molecular conformation change to stimulate the distinct release kinetics of co‐encapsulated therapeutics. In this scenario, doxorubicin is first released to induce immunogenic cell death that intimately works together with the polymerized cytosine‐phosphate‐guanine oligodeoxynucleotide (CpG ODN) in gel scaffold for effectively recruiting and activating dendritic cells. The polymerized CpG ODN not only enhances tumor immunogenicity but minimizes free CpG‐induced splenomegaly. Furthermore, the subsequently released anti‐programmed cell death protein ligand 1 (aPDL1) blocks the corresponding immune inhibitory checkpoint molecule on tumor cells to sensitize antitumor T‐cell immunity. This work thus contributes to the first proof‐of‐concept demonstration of a programmable super‐soft DNA hydrogel system that perfectly matches the synergistic therapeutic modalities based on chemotherapeutic toxicity, in situ vaccination, and immune checkpoint blockade.
- 1 December 2022
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (49) , 55075-55087
Environmentally Stable, Stretchable, Adhesive, and Conductive Organohydrogels with Multiple Dynamic Interactions as High-Performance Strain and Temperature Sensors
- 1 December 2022
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (49) , 55075-55087
Environmentally Stable, Stretchable, Adhesive, and Conductive Organohydrogels with Multiple Dynamic Interactions as High-Performance Strain and Temperature Sensors